PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 31, 20260 citationsOpen Access

An Improved Chemometric Assisted Technique With QBD Approach for Estimation of Telmisartan and Hydrochlorothiazide From Combined Formulation

View Full Paper
GTGurappa Kashinath Dyade*1, Samrudhi Sharad Chavan2, Pranjali Chandrakant Waghmare3, Puja Chatrabhuj Kawade4, Dipali Bhimdevrao Taware5

Key Points

  • The aim is to develop an analytical method using chemometrics and QbD for effective estimation of telmisartan and hydrochlorothiazide.
  • Chemometric-based analytical method was developed using QbD principles on a UV-VIS spectrophotometer.
  • 0.1 N HCl was used as a solvent for drug solutions; absorbance measured at 271.5 nm and 291 nm.
  • Method validation was conducted as per ICH Q 2 R1 guidelines, assessing linearity, accuracy, and precision.
  • Linearity for telmisartan and hydrochlorothiazide observed over a concentration range of 0-24 mcg/ml.
  • Accuracies were SD 1.62621 for telmisartan and 1.89292 for hydrochlorothiazide, within acceptable range.
  • Precision data showed % RSD 1.73061 for telmisartan and 0.91855 for hydrochlorothiazide, indicating the method's reliability.

Abstract

Various pharmaceutical processes including analytical methods are designed and developed by Quality by design approach. Chemometric based analytical method was developed by using principles of QbD for the estimation of telmisartan (TST) and Hydrochlorothiazide (HCTZ) on the UV-VIS spectrophotometer. Ecological suitable solvent 0.1 N HCl was utilised to make solutions; 271.5 nm and 291 nm was the wavelength for absorbance measurement. Effect of input variables on spectrum characteristics were studied for selection of critical parameters and developed method was validated as per ICH Q 2 R1 regulatory guidelines. Linearity of both the drugs was ascertained over the conc range 0-24 mcg/ml. The accuracy was found with SD 1.62621for TST and 1.89292 for HCTZ; and the precision study data % RSD 1.73061 for TST and 0.91855 for HCTZ was found in the acceptable range. The developed method is rigid, robust and efficient for the estimation of TST and HCTZ, from their combined dosage form. QbD was applied to build rigid robust method through risk assessment at early stage and defining the design space at the later stage.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gurappa Kashinath Dyade*1, Samrudhi Sharad Chavan2, Pranjali Chandrakant Waghmare3, Puja Chatrabhuj Kawade4, Dipali Bhimdevrao Taware5 (2026) studied this question.

synapsesocial.com/papers/6a1bd2ab5783ba022b6fe2d1https://doi.org/10.5281/zenodo.20444389
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1QbD‐based development of an extraction procedure for simultaneous quantification of telmisartan, amlodipine besylate and chlorthalidone in combination complex matrix formulation2019 · 17 citations
  2. 2Bioanalytical method development and validation of simultaneous analysis of telmisartan and hydrochlorthiazide in human plasma using LC-MS/MS2016 · 3 citations
  3. 3Method Development and Validation of a Simultaneous Equation Method for UV Spectroscopy-Based Estimation of Rosuvastatin and Telmisartan in Bulk and Dosage Form2026
  4. 4Development and Validation of Spectrophotometric Method for Simultaneous Estimation of Atorvastatin Calcium and Telmisartan in Combined Dosage Form2024
  5. 5ANALYTICAL TECHNIQUES FOR HYDROCHLOROTHIAZIDE AND TRIAMTERENE: DEVELOPMENT, GREENNESS-BY-DESIGN, AND FUTURE PROSPECTS2026